Inclusion Criteria:

1. If female, not of child bearing potential. Defined as females who have had a
hysterectomy or oophorectomy, bilateral tubal ligation or are post-menopausal
(natural or surgical with >1 year since last menstruation). OR Female subject of
childbearing potential must agree to use a medically approved method of birth control
and have a negative urine pregnancy test result.

2. Healthy as determined by laboratory results, medical history and physical exam

3. Agrees to comply with study protocols

4. Has given voluntary, written, informed consent to participate in the study -

Exclusion Criteria:

1. Women who are pregnant, breastfeeding, or planning to become pregnant during the
course of the trial.

2. Gastrointestinal lesions/ulcer, diabetes, or any condition requiring the use of
prescribed medications for treatment

3. Immunocompromised individuals such as subjects that have undergone organ
transplantation or subjects diagnosed with human immunodeficiency virus (HIV)

4. History of or current diagnosis of any cancer (except for successfully treated basal
cell carcinoma) diagnosed less than 5 years prior to screening. Subjects with cancer
in full remission more than 5 years after diagnosis are acceptable.

5. History of bleeding disorders, or significant blood loss in the past 3 months

6. Use of blood thinning medications.

7. Use of anti-inflammatory medications, including over-the-counter pain relievers
within the past 14 days.

8. Use of prescription medication (other than birth control), vitamins, minerals or
other natural health products within the past 3 days. .

9. Alcohol use >2 standard alcoholic drinks per day and/or alcohol or drug abuse within
the past year

10. Allergy or sensitivity to study supplement ingredients, study meal ingredients or
allergy or sensitivity to yeasts or molds/fungi.

11. Participation in a clinical research trial within 30 days prior to randomization

12. Individuals who are cognitively impaired and/or who are unable to give informed
consent

13. Use of fish oil supplements within 10 days of randomization and during the trial

14. Any other condition which in the Investigator's opinion may adversely affect the
subject's ability to complete the study or its measures or which may pose significant
risk to the subject

-